Cervical cancer technology company, TruScreen Ltd (NZAX, TRU), is pleased to announce the appointment of Mr. Con Hickey as an independent director on the TruScreen board.
Mr Hickey has more than 30 years experience in the Medical Device industry, including holding senior executive roles for multinational companies such as Welch Allyn, a leading global manufacturer in frontline diagnostic and screening equipment. Currently the Managing Partner of CONX Partners, Con’s particular skillset includes strategic planning, channel management, talent development and business and market development. His geographic expertise has been focused on the high growth countries of the Asian Pacific region, including China and India, with extensive global industry connections.
Chairman of TruScreen, Mr Robert Hunter, commented: “Mr Hickey brings a wealth of relevant experience to TruScreen. He has a great commercial and sales background, which is ideal for us as we move from a product improvement phase to full scale commercialisation of our unique cancer screening technology.”
Mr Hickey is ordinarily a resident of New Zealand and has been appointed by the current TruScreen directors, as permitted under TruScreen’s constitution. He will hold office until TruScreen’s 2018 Annual Meeting at which time he will offer himself for re-election by shareholders.